Dr. Syed Faisal Mahmood is a Professor and the section head of the Section of Infectious Diseases in the Department of Medicine as well as the Associate Chief Medical Officer at the Aga Khan University Hospital for Infection Prevention and Control. He has a broad background in infectious disease education including the development of the undergraduate curriculum for undergraduate students as well as the establishment of the infectious diseases fellowship program at Aga Khan University. He was also the first conveyor of the faculty of Infectious Diseases at the College of Physicians and Surgeons, the regulatory body to oversee postgraduate medical education and professional development in the country. Before the advent of SARS-CoV2, he was heavily involved in HIV care in the country and continues to be so, working with the WHO, led the development of the last 3 versions of the National treatment guidelines, as well as guidance on Pre-exposure prophylaxis, Differentiated Care Delivery, and HIV Testing and Counselling. He was also responsible for providing training to HIV care providers in the country and more recently in training for PrEP delivery. He was also invited by the WHO and the Sind AIDS Control Program to investigate outbreaks of HIV in a dialysis centre in the city of Larkana followed by an outbreak in children in the same city a few years later. in investigating the HIV outbreak in Larkana. With the arrival of the pandemic, he has been actively involved in working with both the federal and the provincial governments providing advice for risk mitigation. He was also the lead author of the National Guidelines for Management of COVID-19 and contributed to several other guidance documents published by the NIH, Pakistan. At the same time, he is an active clinician, and as the Section Head of Infectious Disease. This year he has also accepted the position of Associate Chief Medical Officer at the Aga Khan University Hospital, in continuation of his work as the Chair of Infection Prevention and Control. Finally, he is actively involved in several clinical trials including 3 COVID vaccine trials (including the country PI for one) and has been part of 5 other COVID-19-related clinical trials and 2 additional grants related to COVID-19. This is in addition to his ongoing work on HIV, including an active grant to study drug resistance in HIV across the country.